Benzomorpholine compounds and uses thereof

By developing benzomorpholine derivatives with TRPM3 antagonistic activity, the problems of drug dependence and side effects of existing pain treatments have been solved, providing a safe and effective treatment for neuropathic pain and migraine.

CN122404248APending Publication Date: 2026-07-17NEURODAWN PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NEURODAWN PHARM CO LTD
Filing Date
2025-01-15
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing pain management drugs have problems such as drug dependence and significant side effects. There is an urgent clinical need for safe, effective, and non-opioid drugs to relieve neuralgia and migraines.

Method used

A class of benzomorpholine derivatives with TRPM3 antagonistic activity has been developed for the preparation of drugs to treat neuralgia or migraine.

Benefits of technology

This compound can effectively relieve neuralgia and migraines, avoiding the drug dependence and side effects of traditional drugs, and providing a new treatment strategy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005242164920000021
    Figure BDA0005242164920000021
  • Figure BDA0005242164920000031
    Figure BDA0005242164920000031
  • Figure BDA0005242164920000041
    Figure BDA0005242164920000041
Patent Text Reader

Abstract

本发明公开了一类苯并吗啉类化合物及其用途，属于制药领域，本发明的苯并吗啉类衍生物是一种具有TRPM3拮抗活性的化合物，具有重要的潜在治疗价值，在治疗神经病理性疼痛或偏头痛药物中的应用。
Need to check novelty before this filing date? Find Prior Art